News

The FDA cleared the investigational new drug application of IDE849, a potential first-in-class DLL3-targeted antibody-drug ...
A company product sold by Trader Joe's, the Sesame Miso Salad with Salmon, has been recalled affecting 18 states after some ...
A salsa product recalled in April due to the possible presence of wood has now been issued a Class II risk classification by the FDA.
A California-based company has announced a recall of salsa products that may be contaminated with small wood particles.
The mislabeling of allergens is a leading cause of food recalls in the U.S., and can have serious or life-threatening implications for those with allergies.
The FDA issued an RTF for sBLA of nogapendekin alfa plus BCG for BCG-unresponsive NMIBC papillary disease, following prior ...
The company stated that it has installed 37 systems, which have been used in over 750 multi-specialty surgeries.
ISB 2001 is a tri-specific antibody therapeutic for targeting BCMA and CD38 on myeloma cells, as well as CD3 on T cells.
The FDA has approved Johnson & Johnson’s drug Imaavy for the treatment of generalized myasthenia gravis, a chronic autoimmune neuromuscular disorder. The approval covers adults and pediatric patients ...
A recall of seafood burgers has been updated to the highest risk by the U.S. Food and Drug Administration. Connecticut-based company Caraluzzi’s Markets initiated the recall in April because its ...
SS Innovations International, Inc. (the "Company” or "SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and ...
IGI, Inc., a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, ...